Honors, Awards, and Recognition

Presidential Award for the Poster "Antibiotic associated microbiome changes in healthy volunteers and corrective impact of the probiotic Saccharomyces Boulardii, Americal College of Gastroenterology

2014

Invited to DDW 2011 to give an oral presentation of selected poster titled " Not All that Flattens is Celiac Disease: The differential of Celiac disease in a contemporary practice", Digestive Disease Week

2011

Passed Second Year Medical School with Academic Distinction, Kasturba Medical College

2002

Passed First Year Medical School with Academic Distinction, Kasturba Medical College

2000

Professional Membership and Service

American Society of Gastrointestinal Endoscopy, Member

American Neurogastroenterology and Motility Society, Member

American Gastroenterology Association, Member

American College of Gastroenterology, Member

Committee Service

UMMC Gastroenterology Clinical Competency Committee: As per Accreditation Council on Graduate Medical Education (ACGME) common program requirements, the Digestive Diseases Fellowship Program at the University of Mississippi Medical Center has established a Clinical Competency Committee (CCC). This CCC is designed to bring insight and perspectives of a group of faculty members to the trainee evaluation process. The CCC also serves as an early warning system if a trainee fails to progress in the educational program, and assists in his/her early identification and move towards improvement and remediation. As a member of CCC I meet with the other members at least semiannually to review all assessments of all the fellows and determine each trainee's current performance level by group consensus. We use multi-source assessment data and faculty member observation to make this assessment., Member

2019 - Present

Department of medicine Mortality Review Committee: This committee consists of providers from different specialties. It reviews specific inpatient mortalities periodically in order to identify avoidable gaps in communication or clinical care that may lead to better outcomes and mortality reduction. As a part of this committee, I receive invitations to review charts of deceased patients and help identify if there were any deficiencies in clinical care, documentation or communication that may have contributed to the primary outcome., Member

2018 - Present

Other Service

Editorial Review Board Member for World Journal Hepatology and World Journal of Gastrointestinal Pathophysiology

06/2018 - Present

Ad Hoc Reviewer for multiple high quality journals including Video Gastrointestinal Endoscopy, World Journal of Gastroenterology, World Journal of Gastrointestinal Oncology, World Journal of Hepatology, World Journal of Clinical Cases, Allergy, Journal of Clinical Lab Analysis, The Lancet Gastroenterology and Hepatology, BMC Research notes and Advances in clinical chemistry. Overall peer reviewed more than 30 journal articles.

05/2014 - Present

Sponsored Program Funding

Extramural, Co-Investigator: The HepQuant SHUNT Liver Diagnostic Kit for the likelihood of large esophageal varices: The SHUNT-V Study, Hepquant LLC

Ustekinumab is a fully human immunoglobulin GI kappa monoclonal antibody to human interleukin (il) 12/23p40 that binds with high affinity to human IL-23. Abnormal regulation of IL-12 and IL-13 has been associated with multiple immune-mediated diseases, including inflammatory bowel disease, and Crohn's disease. The study looked at the clinical response in subjects with moderately to severely active Crohn's disease., Janssen Pharmaceutica, LP

02/2014 - 11/2014

Extramural, Research Assistant: Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonia with an Episode of Hepatic Encephalopathy-STOP-HE

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating OCR-002 which is an investigational medication that will bind to ammonia. Ammonia is considered to be responsible for worsening of the brain function in patients with cirrhosis named hepatic encephalopathy. The study investigated whether study drug can improve HE when administered in addition to best current medical treatment., Ocera Therapeutics, Inc.

Poster Presentation, Histologic features can distinguish non-celiac causes of villous atrophy from those of celiac disease, US & Canadian Academy of Pathology Annual Meeting March 2 - 8, 2013, Baltimore, MA

Biography

Born in 1980 to a physician couple, I grew up in a family full of physicians. Driven by the sense of professional satisfaction that my parents enjoyed despite the tedious nature of their jobs, inspired me to be a physician. I secured a spot at the Kasturba Medical College and graduated in 2005 with a 'Bachelor in Medicine and Surgery' (M.B.B.S) degree. My pursuit for higher education brought me to America, and I completed my Internship and Internal medicine residency at Long Island College Hospital, Brooklyn, NY. After completing my residency in 2010, I attended Harvard University for two years as a clinical and research fellow in Celiac DIsease at the Beth Israel Deaconess Medical Center, Boston, MA. I completed a formal Gastroenterology & Hepatology fellowship at the University of Mississippi Medical Center in 2015 and stayed on as a faculty within my division.